Investor Relations
Global Navigation
- About Us
- Research and Development
- Products
-
- Resources
- AppTrim® Data Sheet
- AppTrim-D® Data Sheet
- GABAdone® Data Sheet
- Hypertensa® Data Sheet
- Lister V® Data Sheet
- Sentra AM® Data Sheet
- Sentra PM® Data Sheet
- Theramine® Data Sheet
- Trepadone® Data Sheet
- AppTrim® Monograph
- Apptrim Monograph® Monograph
- GABAdone® Monograph
- Hypertensa® Monograph
- Lister V® Monograph
- Sentra Am® Monograph
- Sentra PM® Monograph
- Theramine® Monograph
- Trepadone® Monograph
- Quick Links
- none
-
- Safety and Clinical Data
- Investor Relations
-
- Resources
- News
- Quick Links
- Request Information
-
- Careers
- Contact Us
Los Angeles, May 2, 2012 – Physician Therapeutics, Inc., a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that manufactures and distributes specialty pharmaceuticals to physicians, pharmacies and skilled nursing facilities, published results from a clinical trial of the proprietary medical food Sentra PM. This trial demonstrated improved sleep latency and improved [...]
Physician Therapeutics, a division of Targeted Medical Pharma Inc. will be exhibiting at the Freedom and Recovery, Integrated Mental Health and Addiction Treatment Conference for serivce memebers and first responders, April 23-26, 2012 at the Hotel del Coronado in San Diego, CA. The exhibit will feature updated clinical data regarding the nutritional management of [...]
Los Angeles, CA, November 14, 2011
Targeted Medical Pharma Inc. which develops and sells medical food products through its subsidiary Physician Therapeutics, exhibited product information and technology related to its medical foods addressing pain management and sleep disorders related to Post Traumatic Stress Disorder to over 2000 active and retired United States Military pharmacists, service men and women at the Joint [...]
Grants Cover Theramine® , Sentra PM®, Sentra AM® and GABAdone®
Los Angeles, CA, Nov. 1, 2010 /Targeted Medical Pharma Inc. a Specialty Pharma company developing proprietary medical food products distributed through subsidiary Physician Therapeutics announced it has been awarded $733,429.00 in government grants. Under the recently enacted Patient Protection and Affordable Care Act, cash grants [...]
Read article “Double-Blind Clinical Trial of Theramine Published in the American Journal of Therapeutics” here.
In January of 2009 Physician Therapeutics, a wholly owned subsidiary of Targeted Medical Pharma Inc., initiated A Double Blind randomized controlled trial of single dose Naproxen and an amino acid Medical Food Theramine for the treatment of low back pain. Using 10 national sites over a 28 day period, this study consisted of 127 patients [...]
Categories
Recent News
- Clinical Trial Shows Sentra PM® Improves Quality of Sleep
- Physician Therapeutics to Exhibit April 23-26, 2012 in San Diego, CA
- Targeted Medical Pharma Exhibits at the 2011 JFPS in Dallas, Texas
- Targeted Medical Pharma Awarded $733,429.00 in Qualifying New Therapeutic Discovery Grants
- Double-Blind Clinical Trial of Theramine Published in the American Journal of Therapeutics